NCT04941157

Brief Summary

This is a pilot study to be performed at the University of Alabama at Birmingham (UAB) and the University of Massachusetts to determine the feasibility and develop the processes for a future randomized controlled trial to evaluate the occurrence of spinal cord ischemia after endovascular thoracoabdominal aneurysm repair using prophylactic cerebrospinal fluid drains versus no pre-emptive drain. The research question to be addressed is as follows: In the setting of a comprehensive spinal cord ischemia prevention protocol, do prophylactic CSF drains decrease the rate of spinal cord ischemia (SCI) in patients undergoing endovascular thoracoabdominal aneurysm repair?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 28, 2021

Completed
1.3 years until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

January 10, 2025

Status Verified

January 1, 2025

Enrollment Period

1.6 years

First QC Date

June 10, 2021

Last Update Submit

January 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of Spinal Cord Ischemia Onset

    The primary outcome of this study is the rate of post-operative spinal cord ischemia. Onset of spinal cord ischemia will be defined by any new lower extremity neurologic deficit not attributable to another cause. Details of lower extremity neurologic exam will be collected during physical exam. Motor weakness will be measured using the Muscle Power Scale.

    Baseline to 1 year

Study Arms (2)

Prophylactic cerebrospinal fluid drain placement

EXPERIMENTAL

Patients randomized to receive the experimental treatment will have a prophylactic cerebrospinal fluid drain placed prior to their endovascular aortic repair. All components of the endovascular aortic repair are standard of care treatments.

Procedure: Cerebrospinal Fluid Drain Placement

Selective cerebrospinal fluid drain placement

NO INTERVENTION

Patients randomized to the control arm of the study will not receive a prophylactic cerebrospinal fluid drain prior to their endovascular aortic repair. Patients will receive a CSF drain post-operative as needed to treat any symptoms of spinal cord ischemia. This arm of the study is current standard of care.

Interventions

Prophylactic CSF Spinal Drain to be placed prior to surgery in patients randomized to the experimental arm of the study

Prophylactic cerebrospinal fluid drain placement

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18
  • Undergoing high risk endovascular thoraco-abdominal aortic aneurysm repair, based on aortic coverage length:
  • a: Extent I, II, III TAAA 2b: Extent IV TAAA with \>5cm coverage above the celiac artery

You may not qualify if:

  • Active prison incarceration
  • active pregnancy
  • moribund patients
  • ruptured aneurysm
  • coagulopathy precluding CSF drain placement
  • urgent or emergent aneurysm repairs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Univeristy of Alabama at Birmingham Hospital

Birmingham, Alabama, 35213, United States

Location

UMass Memorial Health Hospital

Worcester, Massachusetts, 01655, United States

Location

MeSH Terms

Conditions

Spinal Cord Ischemia

Condition Hierarchy (Ancestors)

Spinal Cord Vascular DiseasesSpinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Adam W Beck, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery

Study Record Dates

First Submitted

June 10, 2021

First Posted

June 28, 2021

Study Start

October 1, 2022

Primary Completion

May 1, 2024

Study Completion

May 1, 2024

Last Updated

January 10, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

Data will be collected electronically from UAB powerchart and stored in an encrypted and secure REDCap database (advanced clinical software application for data warehousing and healthcare analytics related to clinical trials) maintained centrally by UAB. Access to data will be limited to remembers of the research team identified on this IRB proposal. All shared data will be deidentified and related to procedural details and clinical outcomes. Data will be shared with the research team at the University of Massachusetts.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
1 month to 1 year
Access Criteria
Access to data will be limited to remembers of the research team identified on this IRB proposal.

Locations